SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
SEC Accession No. 0001193125-20-290303
Filing Date
2020-11-10
Accepted
2020-11-10 17:13:52
Documents
10
Effectiveness Date
2020-11-10

Document Format Files

Seq Description Document Type Size
1 S-3ASR d862544ds3asr.htm S-3ASR 396265
2 EX-1.2 d862544dex12.htm EX-1.2 194874
3 EX-4.6 d862544dex46.htm EX-4.6 318632
4 EX-4.9 d862544dex49.htm EX-4.9 99315
5 EX-4.10 d862544dex410.htm EX-4.10 100161
6 EX-4.11 d862544dex411.htm EX-4.11 87902
7 EX-5.1 d862544dex51.htm EX-5.1 34659
8 EX-23.1 d862544dex231.htm EX-23.1 1685
9 GRAPHIC g862544g1110114140894.jpg GRAPHIC 2538
10 GRAPHIC g862544g54j15.jpg GRAPHIC 28858
  Complete submission text file 0001193125-20-290303.txt   1278099
Mailing Address 499 ILLINOIS STREET SUITE 500 SAN FRANCISCO CA 94158
Business Address 499 ILLINOIS STREET SUITE 500 SAN FRANCISCO CA 94158 415-906-4324
Vir Biotechnology, Inc. (Filer) CIK: 0001706431 (see all company filings)

IRS No.: 812730369 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3ASR | Act: 33 | File No.: 333-250013 | Film No.: 201302122
SIC: 2836 Biological Products, (No Diagnostic Substances)